Randall B. Sunberg


Counseling clients ranging from biotech startups to multinational pharmaceutical companies, Randall B. Sunberg structures and negotiates complex collaborations, mergers and acquisitions, divestitures, joint ventures, and corporate partnering and licensing transactions, as well as equity investments and royalty monetization transactions. In addition to pharma, biotech, medical device, diagnostics, and technology companies, Randy advises private equity, venture capital, and investment banking firms. He is co-leader of the firm’s life sciences interdisciplinary group and leader of the life sciences transactions practice.